
Preclinical data on lead coronaviruses antibody
Adagio Therapeutics today published in vitro and in vivo data in Science on its lead antibody candidate, ADG2, which demonstrated similar or higher potency against SARS-CoV-2 compared to other monoclonal antibodies (mAbs) ...
Jan 25, 2021
0
2